‘Staggering’ weight loss with tirzepatide
Substantial reductions in body weight across body mass index (BMI) categories, as well as improved body composition, were achieved with tirzepatide (Mounjaro) in adults for
Substantial reductions in body weight across body mass index (BMI) categories, as well as improved body composition, were achieved with tirzepatide (Mounjaro) in adults for
Diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are being studied to tackle some of the most difficult-to-treat brain disorders, including
New research presented at the Diabetes UK Professional Conference 2023 has revealed that a molecule secreted by frogs could offer a new treatment option for
Patients taking metformin for Type 2 diabetes had a lower risk of developing osteoarthritis than did patients taking a sulfonylurea, according to a study published
The European Commission (EC) has given authorization for ruxolitinib (Opzelura) cream 15 mg/g to be marketed for treating nonsegmental vitiligo, a chronic autoimmune disease characterized by
America’s Food and Drugs Administration (FDA) recently cleared for a phase 2 clinical trial a new drug for Type 1 diabetes which would be the
The BBC has reported that a weight loss jab that has gained popularity in the US has been approved for use by the NHS in
The Royal Mail has teamed up with Pharmacy2U, the UK’s largest online pharmacy, to offer a complete NHS prescription service that enables patients to order
The US Food and Drug Administration has approved a new medication for Type 2 diabetes called Brenzavvy. This belongs to a class of drugs known
Although half of patients with Type 2 diabetes (T2D) in France have blood glucose levels that are outside of their target range, an international consensus suggests that